Cancer treatment-related cardiac dysfunction. Issue 1 (26th July 2022)

• Record Type: Journal Article
• Authors: Brady, Bernadette; Murphy, Ross
• Is Part Of: BMJ supportive & palliative care. Volume 13:Issue 1(2023)
• Page Start: 53
• Page End: 56
• Publication Date: 2022-07-26
• Subjects: cancer -- heart failure -- clinical decisions; Palliative treatment -- Periodicals; Terminal care -- Periodicals; 616.029
• DOI: 10.1136/spcare-2022-003832
• Languages: English
• ISSNs: 2045-435X

Abstract

Abstract : Objectives: This paper describes cardiotoxicity and cancer treatment-related cardiac dysfunction (CTRCD). Long-term sequelae of treatment are important, and changing, and may manifest when a patient is under the care of a supportive care service. Methods: Key messages for supportive and palliative care clinicians are outlined to facilitate identification and management of CTRCD. Results: Not all cardiotoxicity is alike. Types of cardiotoxicity, cardiac complications of immunotherapy, the challenge of autonomic nervous system dysfunction in cancer and management of cardiotoxicity are highlighted. Conclusions: The key strategies are early detection of cardiotoxicity, monitoring for development of CTRCD during treatment and surveillance in survivorship.